Human papillomavirus (HPV) vaccination uptake varies by geographic regions with rural, often medically underserved areas, lagging behind more urban regions in terms of vaccine initiation and completion. In these regions, pharmacies may serve as an additional location for HPV vaccine administration. Little is known about rural caregivers’ willingness to have their HPV vaccine age-eligible children obtain this vaccine from their local pharmacist. First and second authors conducted 26 in-depth interviews with caregivers of HPV vaccine age-eligible children living in rural regions of a southwestern state to explore their perceptions of the HPV vaccine and their willingness for pharmacist-administered HPV vaccination. They analyzed interview data using an inductive qualitative content analyses approach. The majority of caregivers were unaware that pharmacists could offer adolescent vaccines. However, most were willing to allow their children to receive the vaccine from this non-traditional source. Comments related to obtaining vaccinations from pharmacists related mostly to concerns about proper training and their certification to vaccinate against HPV. Caregivers believed that having a pharmacist administer the HPV vaccine would not affect their relationship with their primary care provider. Caregivers preferred print health education resources and were interested in also receiving health information via social media to learn more about the HPV vaccine and pharmacists’ role in HPV vaccine administration. Pharmacies may serve as an additional site to increase HPV vaccine initiation and completion. Rural regions need additional health information about the HPV vaccine and pharmacists’ abilities to administer this cancer prevention resource.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C (2015) US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 107(6):djv086
Zahnd W, James AS, Jenkins WD, Izadi SR, Fogleman AJ, Steward DE, Colditz GA, Brard L (2017) Rural-urban differences in cancer incidence and trends in the United States. Cancer Epidemiol Biomark Prev 27:1265–1274
Centers for Disease Control and Prevention (2014) CDC grand rounds: reducing the burden of HPV-associated cancer and disease. Morb Mortal Wkly Rep 63(4):69–72
Iversen OE, Miranda MJ, Ulied A, Soerdal T, Lazarus E, Chokephaibulkit K, Block SL, Skrivanek A, Azurah AGNF, Siew M (2016) Immunogenicity of the 9-valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women. JAMA 316(22):2411–2421
Meites E (2016) Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep 65(49):1405–1408
Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams C, Meyer S, Stokley S (2017) National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2016. Morb Mortal Wkly Rep 66(33):874–882
Mohammed KA, Subramaniam DS, Geneus CH, Henderson ER, Dean CA, Subramaniam DP, Burroughs TE (2018) Rural-urban differences in human papillomavirus knowledge and awareness among US adults. Prev Med 109:39–43
Boyd ED, Phillips JM, Schoenberger YM, Simpson (2018) Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers. Vaccine 36(28):4126–4133
Mills LA, Head KJ, Vanderpool RC (2013) HPV vaccination among young adult women: a perspective from Appalachian Kentucky. Prev Chronic Dis 10:E17
Carhart MY, Schminkey DL, Mitchella EM, Keim-Malpass J (2018) Barriers and facilitators to improving Virginia’s HPV vaccination rate: a stakeholder analysis with implications for pediatric nurses. J Pediatr Nurs 42:1–8
Getrich CM, Broidy LM, Kleymann E, Helitzer DL, Kong AS, Sussman AL (2014) Different models of HPV vaccine decision-making among adolescent girls, parents, and health-care clinicians in New Mexico. Ethn Health 19(1):47–63
Sussman AL, Helitzer D, Bennet A, Solares A, Lanoue M, Getrich C (2015) Catching up with the HPV vaccine: challenges and opportunities in primary care. Ann Fam Med 13(4):354–360
Kepka D, Spigarelli MG, Warner EL, Yoneoka Y, McConnell N, Balch A (2016) Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data. Papillomavirus Res 2:128–132
Katz IT, Bogart LM, Fu CM, Liu Y, Cox JE, Samuels RC, Chase T, Schubert P, Schuster MA (2016) Barriers to HPV immunization among blacks and latinos: a qualitative analysis of caregivers, adolescents, and providers. BMC Public Health 16(1):874
Mclean HQ, Birchmeier B, Chow B, Vickrs E, McNeil M, Gee J, Stokley S, Belongia E, Vanwormer J (2016) Health care provider attitudes and barriers regarding human papillomavirus (HPV) vaccination: factors associated with increasing HPV vaccine coverage before and after an intervention program. Open Forum Infect Dis 3(suppl 1):718
Preciado M, Hudson SM, Rondinelli J, Glenn BA, Chao C (2015) An in-depth interview study of immunization providers to understand practice patterns, barriers and facilitators for administering the 3-dose HPV vaccine series. J Patient Cent Res Rev 2(2):90–91
US Department of Health and Human Services (2014) Accelerating HPV vaccine uptake: Urgency for action to prevent cancer. A report to the President of the United States from the President’s Cancer Panel, National Cancer Institute, Editor. 2014: Bethesda, MD. Accessed from https://deainfo.nci.nih.gov/advisory/pcp/annualreports/hpv/PDF/PCP_Annual_Report_2012-2013.pdf
Fava JP, Colleran J, Bignasci F, Cha R, Kilgore (2017) Adolescent human papillomavirus vaccination in the United States: opportunities for integrating pharmacies into the immunization neighborhood. Hum Vaccin Immunother
Nichols K, Girotto J, Mitchell-Van Steele A, Stofella S (2017) Duty to advocate: human papillomavirus vaccination. J Pediatr Pharmacol Ther 22(1):74–76
Gallup (2018) Honesty/ethics in professions. Accessed from https://news.gallup.com/poll/1654/honesty-ethics-professions.aspx
National Association of Chain Drug Stores, 2010–2011 chain pharmacy industry profile. 2010, NACDS: Alexandria, VA
Hohmeier KC, Randolph DD, Smith CT, Hagemann TM (2016) A multimodal approach to improving human papillomavirus vaccination in a community pharmacy setting. SAGE Open Med 4:1–5
Goad J, Bach A (2015) The role of community pharmacy-based vaccination in the USA: current practice and future directions. Integr Pharm Res Pract 4:67–77
Shah PD, Trogdon JG, Golden SD, Golin CE, Marciniak MW, Brewer NT (2018) Impact of pharmacists on access to vaccine providers: a geospatial analysis. Milbank Q 96(3):568–592
McIntosh J, Sturpe D, Khanna N (2008) Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists. J Am Pharm Assoc 48(1):e1–e16
Rothholz M, Tan L (2017) Promoting the immunization neighborhood: benefits and challenges of pharmacies as additional locations for HPV vaccination. Hum Vaccin Immunother 13(8):1856–1858
Kuper A, Reeves S, Levinson W (2008) An introduction to reading and appraising qualitative research. BMJ 337(7666):404–407
Lombard M, Snyder-Duch J, Bracken CC (2010) Practical resources for assessing and reporting intercoder reliability in content analysis research projects. Accessed from http://matthewlombard.com/reliability/index_print.html#What%20is%20intercoder%20reliability
Sutton J, Austin Z (2015) Qualitative research: data collection, analysis, and management. Can J Hop Pharm 68(3):226–231
Ando H, Cousins R, Young C (2014) Achieving saturation in thematic analysis: development and refinement of a codebook. Compr Psychol 3:4
Islam JY, Gruber JF, Lockhart A, Kunwar M, Wilson S, Smith SB, Brewer NT, Smith JS (2017) Opportunities and challenges of adolescent and adult vaccination administration within pharmacies in the United States. Biomed Inform Insights 9:1178222617692538
Shah P, Calo WA, Marciniak MW, Gilkey MB, Brewer N (2018) Support for pharmacist-provided HPV vaccination: national surveys of US physicians and parents. Cancer Epidemiol Biomark Prev 27(8):970–978
Arizona State Legislature, A.S., 32-1974. Pharmacists’ administration of immunizations, vaccines and emergency medications; certification; reporting requirements; advisory committee; definitions. 2007. Accessed from https://www.azleg.gov/viewDocument/?docName=http://www.azleg.gov/ars/32/01974.htm
Swiecki-Sikora AL, Henry KA, Kepka D (2019) HPV vaccination coverage among US teens across the rural-urban continuum. J Rural Health. https://doi.org/10.1111/jrh.12353
Goad JA, Taitel MS, Fensterheim LE, Cannon AE (2013) Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience. Ann Fam Med 11(5):429–436
Rock C, de Barra E, Sadlier C, Kelly S, Dowling C, McNally C, Bergin C (2013) Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort. J Infect Public Health 6(3):173–178
Van Dyne EA, Jnley SJ, Saraiya M, Thomas CC, Markowtiz LE, Benard VB (2018) Trends in human papillomavirus–associated cancers—United States, 1999–2015. Morb Mortal Wkly Rep 67(33):918–924
DeStefano F, Bodenstab HM, Offit PA (2019) Principal controversies in vaccine safety in the United States. Clin Infect Dis ciz135, https://doi-org.ezproxy1.lib.asu.edu/10.1093/cid/ciz135
Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis R, Markowitz L (2014) Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014—United States. Morb Mortal Wkly Rep 63(29):620–624
Kata A (2002) Anti-vaccine activists, Web 2.0, and the postmodern paradigm—an overview of tactics and tropes used online by the anti-vaccination movement. Vaccine 30(25):3778–3789
Pías-Peleteiro L, Cortés-Bordoy J, Martinón-Torres F (2013) Dr Google: what about the human papillomavirus vaccine? Hum Vaccin Immunother 9(8):1712–1719
Dilley SE, Peral S, Straugh M, Scarinci I (2018) The challenge of HPV vaccination uptake and opportunities for solutions: lessons learned from Alabama. Prev Med 113:124–131
Kepka D, Bodson J, Lai D, Sanchez-Birkead AS, Villalta J, Mukundente V, Tavake-Psi F, Davis FA, Lee D, Napia E, Mooney R, Coulter H, Stark LA (2018) Factors associated with human papillomavirus vaccination among diverse adolescents in a region with low human papillomavirus vaccination rates. Health Equity 2(1):223–232
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Arizona State University Institutional Review Board, STUDY00006995) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Koskan, A.M., Dominick, L.N. & Helitzer, D.L. Rural Caregivers’ Willingness for Community Pharmacists to Administer the HPV Vaccine to Their Age-Eligible Children. J Canc Educ 36, 189–198 (2021). https://doi.org/10.1007/s13187-019-01617-z
- Human papillomavirus
- HPV vaccine
- Primary care